First diagnosis of familial partial lipodystrophy syndrome type 3 during pregnancy associated with a novel heterozygous PPARG variant and a concurrent ABCC8 variant: a case report - Scorecard - MDSpire
Advertisement
First diagnosis of familial partial lipodystrophy syndrome type 3 during pregnancy associated with a novel heterozygous PPARG variant and a concurrent ABCC8 variant: a case report
Clinical Scorecard: Diagnosis of Familial Partial Lipodystrophy Type 3 During Pregnancy Linked to a Novel Heterozygous Variant in PPARG and a Concurrent Variant in ABCC8: A Case Study
At a Glance
Category
Detail
Condition
Familial Partial Lipodystrophy Type 3 (FPLD3)
Key Mechanisms
Loss-of-function mutations in the PPARG gene leading to selective loss of adipose tissue and severe metabolic disturbances.
Target Population
Pregnant women with FPLD3.
Care Setting
Multidisciplinary management in high-risk pregnancy.
Key Highlights
FPLD is characterized by selective loss of adipose tissue and severe metabolic disturbances.
Pregnancy in women with FPLD poses high risks for both mother and fetus.
A novel heterozygous variant in PPARG was identified as likely pathogenic.
Intensive insulin therapy combined with metformin and omega-3 fatty acids stabilized metabolic complications.
Early recognition and multidisciplinary management are crucial for favorable outcomes.
Guideline-Based Recommendations
Diagnosis
Molecular genetic analysis for identifying variants in PPARG and other related genes.
Management
High-dose insulin therapy and metabolic management during pregnancy.
Monitoring & Follow-up
Regular monitoring of triglyceride and blood glucose levels.
Risks
Increased risk of pancreatitis and metabolic complications during pregnancy.
Patient & Prescribing Data
Pregnant women with a history of severe hypertriglyceridaemia and metabolic disorders.
High-dose insulin therapy is essential for managing severe hypertriglyceridaemia in pregnancy.
Clinical Best Practices
Early diagnosis of FPLD is critical in pregnant patients.
Multidisciplinary approach is recommended for managing complex cases.
So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.
